An advanced training course focused on the integration of exosomes, peptides, and cell-based therapies as powerful tools for aesthetic rejuvenation and tissue regeneration.
This course is designed to provide a comprehensive understanding of the underlying science, clinical application protocols, safety profiles, and synergistic potential of these cutting-edge therapeutic approaches.
Package 1
CONFERENCE
September 12th, 2025
Access to international lectures on advanced regenerative medicine.
Key Development and Scientific Advisor in Regenerative Medicine at ISSCA
Dr. Rafael Gonzalez is a globally recognized scientist with over 20 years of experience in regenerative medicine and immune system optimization. Holding a Ph.D. in Anatomy and Neurobiology from the University of California, Irvine, he has specialized in developing stem cell and immune-based interventions for trauma and age-related conditions. He currently serves as Chief Development and Scientific Officer at TheBioBox, leading clinical innovation in natural killer cell and stem cell therapies.
Beyond his leadership roles, Dr. Gonzalez collaborates with institutions like Immunocine and Rehealth, advancing therapeutic strategies that target immune health and longevity. A prominent educator with the American Academy of Anti-Aging Medicine (A4M), he also serves as a key instructor at ISSCA, where he trains clinicians worldwide in regenerative medicine. His research, patents, and global educational efforts continue to shape the future of cell-based therapeutics.
Dr. Matthew Halpert, Ph.D.
Key Expert in Cancer Immunotherapy and Regenerative Medicine at ISSCA
Dr. Matthew Halpert is a renowned scientist specializing in cancer immunotherapy and regenerative medicine. He earned his Ph.D. in Microbiology and Immunology from the University of Alabama at Birmingham and spent a decade at Baylor College of Medicine advancing dendritic cell-based cancer therapies. As founder and CEO of Immunocine Cancer Center and Diakonos Oncology, he has led the development of FDA-approved clinical trials, including a breakthrough glioblastoma treatment.
Dr. Halpert’s work bridges cutting-edge research with real-world clinical solutions, including collaborations with ProPhase Labs on therapeutic and diagnostic oncology. He holds multiple patents and has received numerous accolades, including the 2024 Breakthrough in Cancer award. As an ISSCA instructor, he educates physicians globally on innovative cellular therapies, helping shape the next generation of cancer and regenerative treatments.
Dr. Alan Gaveck
Key Specialist in cellular and stem cell therapies at ISSCA
Dr. Alan Gaveck is a distinguished U.S. physician and leading expert in cellular and stem cell therapies at ISSCA. With decades of experience in regenerative medicine, he is especially known for his pioneering work in exosome-based therapies and for developing advanced treatment protocols that continue to expand the frontiers of cellular medicine. His scientific expertise and dedication to innovation have made him a central figure in ISSCA’s global training programs.
Driven by a patient-centered philosophy, Dr. Gaveck emphasizes excellence and compassion in clinical care. “We opted to take part in healthcare development,” he states—reflecting a vision grounded in progress and human connection. As one of ISSCA’s top international speakers, he regularly shares the latest insights in regenerative therapies with physicians worldwide, empowering them with cutting-edge knowledge and practical applications.
Day 1 | September 12th, 2025
The ISSCA Global Summit is more than a medical event—it’s the global gathering that defines the future of regenerative medicine. Over two intensive days in Cancun, professionals from 30+ countries come together to learn the latest techniques, technologies, and protocols in cellular therapies, aesthetic regeneration, longevity, metabolism, functional orthopedics, and immunotherapy.
Day 1 delivers an unparalleled academic experience: an international conference featuring more than 18 world-class speakers carefully selected by our scientific committee. Experts come from Japan, the U.S., Europe, Latin America, and the Middle East. Each session offers clinically applicable insights, focused on real-world outcomes backed by scientific evidence. The day concludes with MedConnect—a night of global medical networking and dinner at one of Cancun’s most iconic venues.
Day 2 is dedicated exclusively to clinical training. ISSCA offers hands-on certifications in the most impactful areas of modern medicine: immunomodulation, longevity, MUSE Cells, sports medicine, aesthetics, and peptide therapies. This is where global medical leaders are formed, alliances are built, and cutting-edge tools are brought into clinical practice. Missing this event isn’t just missing out on the year’s top conference—it’s staying behind in the most innovative field in medicine today.
The ISSCA Global Summit is not just an educational experience it is a statement of global medical leadership.
The Global Epicenter of Regenerative Medicine
Day 2 | September 13th, 2025
ISSCA Certification in Next-Generation Cellular Therapies
A comprehensive training program focused on the clinical use of allogeneic cellular products derived from umbilical cord tissue, including mesenchymal stem cells, exosomes, secretomes, and natural killer (NK) cells. This course equips physicians to integrate cellular therapies into the treatment of degenerative, musculoskeletal, immunological, metabolic, and neurological conditions, supported by scientific evidence.
Includes continuous access to updated training materials developed by ISSCA faculty based on clinical experience and scientific literature. While your certification remains valid, updates are included at no additional cost.
Why This Training is Essential
Exclusive access: Direct training with clinical instructors actively applying these therapies in practice.
Therapeutic relevance: Evidence-based protocols for real-world pathologies.
Immediate applicability: Ready-to-use materials, forms, and resources for professional implementation.
Fundamentals of cell biology and perinatal tissue: Origins and properties of allogeneic mesenchymal stem cells, including quality standards, tissue banking, post-thaw viability, and microbiological validation.
Safe routes of administration (IV, IM, intra-articular, intrathecal): Practical training on application techniques based on pathology type, dosing parameters, post-treatment monitoring, and treatment traceability.
Patient selection criteria: Clinical history assessment, comorbidities, biomarker analysis, and diagnostic tools to determine patient eligibility.
Use of exosomes and secretome in inflammatory settings: Understanding paracrine mechanisms, immunomodulatory effects, and regenerative cascades supported by clinical and preclinical data.
Orthopedic applications: Protocols for osteoarthritis, patellofemoral syndrome, sports injuries, and accelerated functional recovery.
Aesthetic and hair restoration applications: Approaches to alopecia, skin aging, scar treatment, hyperpigmentation, and photodamage.
Neurological applications: Treatment of cognitive decline, peripheral neuropathies, multiple sclerosis, and neurodegenerative prevention.
Metabolic applications: Management of insulin resistance, mitochondrial dysfunction, chronic low-grade inflammation, and lipid profiles.
NK cell therapy: Introduction to cellular immunotherapy, mechanisms of targeted cytotoxicity, potential benefits in integrative oncology, and control of persistent infections.
Musculoskeletal disorders: Osteoarthritis, tendinopathies, joint injuries, chronic low back pain, bursitis, and tendon tears.
